Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients

被引:273
作者
Groenvold, Mogens
Petersen, Morten Aagaard
Idler, Ellen
Bjorner, Jakob Bue
Fayers, Peter M.
Mouridsen, Henning T.
机构
[1] Bispebjerg Hosp, Res Unit, Dept Palliat Med, DK-2400 Copenhagen, Denmark
[2] Univ Copenhagen, Inst Publ Hlth, Copenhagen 2200, Denmark
[3] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA
关键词
breast neoplasms; survival; psychological distress; quality of Life; psychoneuroimmunology; prognostic factors;
D O I
10.1007/s10549-006-9447-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study examined whether psychological distress in newly diagnosed breast cancer patients was associated with their survival. We analyzed data from 1,588 breast cancer patients who filled in the EORTC QLQ-C30 questionnaire and the Hospital Anxiety and Depression Scale (HADS) 2 months after their primary operation. The median follow-up time was 12.9 years. Psychological distress (EORTC QLQ-C30 emotional function; HADS anxiety; HADS depression) and EORTC fatigue, physical function, and overall ratings were used to predict recurrence-free and overall survival, controlling for the known clinical and histopathological prognostic factors (biological model) using Cox multivariate regression analysis. Low levels of psychological distress (good EORTC emotional function) and low fatigue independently predicted longer recurrence-free and overall survival, controlling for biological factors. Lack of anxiety (HADS) also predicted longer recurrence-free survival. When added in combination to the biological model, fatigue remained a significant predictor of recurrence-free survival (P = 0.0004; risk ratio 1.32 (1.13-1.54)) and emotional function remained a significant predictor of overall survival (P = 0.0074; risk ratio 0.81 (0.70-0.95)). Low psychological distress and a low level of fatigue may cause a greater cancer resistance or may reflect underlying mental and physical robustness.
引用
收藏
页码:209 / 219
页数:11
相关论文
共 48 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Abe O, 1998, LANCET, V352, P930
  • [3] Bjorner J. B., 1996, SELFRATED HLTH USEFU
  • [4] PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES IN A TRIAL OF CHEMOTHERAPY WITH OR WITHOUT INTERFERON IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    COATES, A
    THOMSON, D
    MCLEOD, GRM
    HERSEY, P
    GILL, PG
    OLVER, IN
    KEFFORD, R
    LOWENTHAL, RM
    BEADLE, G
    WALPOLE, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1731 - 1734
  • [5] PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER
    COATES, A
    GEBSKI, V
    SIGNORINI, D
    MURRAY, P
    MCNEIL, D
    BYRNE, M
    FORBES, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) : 1833 - 1838
  • [6] Quality-of-life scores predict outcome in metastatic but not early breast cancer
    Coates, AS
    Hürny, C
    Peterson, HF
    Bernhard, J
    Castiglione-Gertsch, M
    Gelber, RD
    Goldhirsch, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3768 - 3774
  • [7] Cunningham AJ, 1998, PSYCHO-ONCOL, V7, P508, DOI 10.1002/(SICI)1099-1611(199811/12)7:6<508::AID-PON376>3.0.CO
  • [8] 2-7
  • [9] *DAN BREAST CANC C, 1989, PROGR TREATM FOLL PA
  • [10] Baseline FACT-G score is a predictor of survival for advanced lung cancer
    Dharma-Wardene, M
    Au, HJ
    Hanson, J
    Dupere, D
    Hewitt, J
    Feeny, D
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (07) : 1209 - 1216